| James Robert Crowe, CRNA | |
|
809 University Blvd E, Tuscaloosa, AL 35401-2029 | |
| (205) 759-7352 | |
| (205) 759-6397 |
| Full Name | James Robert Crowe |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 25 Years |
| Location | 809 University Blvd E, Tuscaloosa, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104867894 | NPI | - | NPPES |
| 051256 | Other | AL | AMERICAN ASSOCIATION OF NURSE ANESTHETISTS (CERTIFICATION) |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 1-076304 (Alabama) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 1-076304 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| D C H Regional Medical Center | Tuscaloosa, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capstone Anesthesia Services Llc | 0648401679 | 4 |
| Dch Medical Center Crna | 5395933626 | 33 |
News Archive
The study examined the effectiveness of For Keeps, an abstinence-until-marriage sex education program that has been presented to more than 25,000 students at public and private schools in the Greater Cleveland area.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces the release of a letter from Paul Dwork, Pharmacist, and President of Merlin Medical Supply Pharmacy, endorsing the many benefits of the Protectus Safety Syringe.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
Radiation therapy used to treat uterine cancer may increase a patient's risk of developing bladder cancer. That is the conclusion of a recent study published in BJU International.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
› Verified 9 days ago
| Entity Name | Tombigbee Healthcare Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578690327 PECOS PAC ID: 6709873235 Enrollment ID: O20040427001551 |
News Archive
The study examined the effectiveness of For Keeps, an abstinence-until-marriage sex education program that has been presented to more than 25,000 students at public and private schools in the Greater Cleveland area.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces the release of a letter from Paul Dwork, Pharmacist, and President of Merlin Medical Supply Pharmacy, endorsing the many benefits of the Protectus Safety Syringe.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
Radiation therapy used to treat uterine cancer may increase a patient's risk of developing bladder cancer. That is the conclusion of a recent study published in BJU International.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
› Verified 9 days ago
| Entity Name | Dch Medical Center Crna |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356642045 PECOS PAC ID: 5395933626 Enrollment ID: O20101230000396 |
News Archive
The study examined the effectiveness of For Keeps, an abstinence-until-marriage sex education program that has been presented to more than 25,000 students at public and private schools in the Greater Cleveland area.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces the release of a letter from Paul Dwork, Pharmacist, and President of Merlin Medical Supply Pharmacy, endorsing the many benefits of the Protectus Safety Syringe.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
Radiation therapy used to treat uterine cancer may increase a patient's risk of developing bladder cancer. That is the conclusion of a recent study published in BJU International.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
› Verified 9 days ago
| Entity Name | Capstone Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073934675 PECOS PAC ID: 0648401679 Enrollment ID: O20140314001809 |
News Archive
The study examined the effectiveness of For Keeps, an abstinence-until-marriage sex education program that has been presented to more than 25,000 students at public and private schools in the Greater Cleveland area.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces the release of a letter from Paul Dwork, Pharmacist, and President of Merlin Medical Supply Pharmacy, endorsing the many benefits of the Protectus Safety Syringe.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
Radiation therapy used to treat uterine cancer may increase a patient's risk of developing bladder cancer. That is the conclusion of a recent study published in BJU International.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
› Verified 9 days ago
| Entity Name | Fayette Medical Center-crna |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194147637 PECOS PAC ID: 2365673415 Enrollment ID: O20140402002181 |
News Archive
The study examined the effectiveness of For Keeps, an abstinence-until-marriage sex education program that has been presented to more than 25,000 students at public and private schools in the Greater Cleveland area.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces the release of a letter from Paul Dwork, Pharmacist, and President of Merlin Medical Supply Pharmacy, endorsing the many benefits of the Protectus Safety Syringe.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
Radiation therapy used to treat uterine cancer may increase a patient's risk of developing bladder cancer. That is the conclusion of a recent study published in BJU International.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Robert Crowe, CRNA 809 University Blvd E, Tuscaloosa, AL 35401-2029 Ph: (205) 759-7352 | James Robert Crowe, CRNA 809 University Blvd E, Tuscaloosa, AL 35401-2029 Ph: (205) 759-7352 |
News Archive
The study examined the effectiveness of For Keeps, an abstinence-until-marriage sex education program that has been presented to more than 25,000 students at public and private schools in the Greater Cleveland area.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces the release of a letter from Paul Dwork, Pharmacist, and President of Merlin Medical Supply Pharmacy, endorsing the many benefits of the Protectus Safety Syringe.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
Radiation therapy used to treat uterine cancer may increase a patient's risk of developing bladder cancer. That is the conclusion of a recent study published in BJU International.
Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a biomarker of islet cell function, compared to controls.
› Verified 9 days ago
Tonya Via, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-759-7755 | |
Mr. Joseph Lee Stork Jr., CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-759-7111 | |
Mr. Arvil Boler Miller, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 809 University Blvd E, -, Tuscaloosa, AL 35401 Phone: 205-759-7111 | |
Soon Ja Stanley, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-759-7352 Fax: 205-759-6397 | |
Melissa Newell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1400 Mcfarland Blvd N, Tuscaloosa, AL 35406 Phone: 205-345-5500 Fax: 205-502-5152 | |
Lisa J. Pennington, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1400 Mcfarland Blvd N, Tuscaloosa, AL 35406 Phone: 205-345-5500 Fax: 205-502-5152 | |
Laura Carter Foster, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 809 University Blvd E, Tuscaloosa, AL 35401 Phone: 205-759-7111 |